Discover 1,461 paid clinical trials in Tacoma, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,461
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
for
Osteoarthritis, Overweight or Obesity
Location: Kirkland WA, Ammon ID, Walnut Creek CA, South Jordan UT,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07353931
Phase 3, Recruiting
A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
for
Pulmonary Disease, Chronic Obstructive
Location: Kirkland WA, Kelowna, Newport Beach CA, Denver CO,
Sponsor: Eli Lilly and Company
Sex: All
Age: 40 - 70+
Code: NCT07759245
Phase 2, Recruiting
Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis
for
Lewy Body Dementia Psychosis
Location: Kirkland WA, Irvine CA, Aurora CO, Kansas City KS,
Sponsor: ACADIA Pharmaceuticals Inc.
Sex: All
Age: 55 - 70+
Code: NCT07029581
Phase 2, Recruiting
A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity
for
Multiple Sclerosis Spasticity
Location: Kirkland WA, Edmonton, Scottsdale AZ, Kansas City KS,
Sponsor: Celgene
Sex: All
Age: 18 - 70
Code: NCT06782490
Phase 2, Recruiting
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
for
Major Depressive Disorder (MDD),
Location: Everett WA, Glendale CA, San Jose CA, Redlands CA,
Sponsor: Seaport Therapeutics
Sex: All
Age: 18 - 65
Code: NCT07065240
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Phase 3, Open Label Extension Study of ACP-204 in Lewy Body Dementia Psychosis
for
Lewy Body Dementia Psychosis
Location: Kirkland WA, Irvine CA, Kansas City KS, Tulsa OK,
Sponsor: ACADIA Pharmaceuticals Inc.
Sex: All
Age: 55 - 70+
Code: NCT07095465
Phase 3, Recruiting
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
for
Cognitive Dysfunction, Lewy Body Disease, Synucleinopathies,
Location: Kirkland WA, Portland OR, Palo Alto CA, Irvine CA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 55 - 70+
Code: NCT07589595
Phase 2, Recruiting
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease